Is a complete ALXO research report available?

No complete published report is available for ALX Oncology Holdings Inc. (ALXO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ALX Oncology Holdings Inc. (ALXO)

NASDAQ: ALXO · USD

$1.17

+0.07 (+6.4%)· Recorded snapshot

Market cap	161.8M
Net income (ttm)	-80.9M
EPS (ttm)	-$0.93
Shares out	138.3M
Volume	2,798,530
Beta	0.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -80.9M
EPS (ttm): -$0.93
Market cap: 161.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001810182
Company name	ALX Oncology Holdings Inc.
Country	United States
Country code	US
CUSIP number	00166B105
Earnings date	2026-11-10
Earnings time	bmo
Employees	48
Employees change	-1
Employees growth	-2.04%
Enterprise value	$34.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-07-17
Is primary listing	Yes
Is SPAC	No
ISIN number	US00166B1052
Last 10-K release date	2026-03-09
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$161.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$1.17
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ALXO
U.S. state	California
Website	https://www.alxoncology.com

Metric

Value

Amount currency

USD

CIK code

0001810182

Company name

ALX Oncology Holdings Inc.

Country

United States

Country code

CUSIP number

00166B105

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

-1

Employees growth

-2.04%

Enterprise value

$34.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2020-07-17

Is primary listing

Yes

Is SPAC

ISIN number

US00166B1052

Last 10-K release date

2026-03-09

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$161.8M

Market cap category

Micro-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$1.17

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ALXO

U.S. state

California

Website

https://www.alxoncology.com

Metric	Value
Earnings yield	-79.75%
FCF / EV yield	-209.28%
FCF yield	-44.04%
P/B ratio	1.12x
Price / tangible book value	1.18x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-79.75%

FCF / EV yield

-209.28%

FCF yield

-44.04%

P/B ratio

1.12x

Price / tangible book value

1.18x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.7M
ROA	-40.4%
ROA (5Y)	-36.27%
ROCE	-56.69%
ROE	-80.65%
ROE (5Y)	-73.21%
ROIC	-45.42%

Metric

Value

Profit per employee

$-1.7M

ROA

-40.4%

ROA (5Y)

-36.27%

ROCE

-56.69%

ROE

-80.65%

ROE (5Y)

-73.21%

ROIC

-45.42%

Metric	Value
EPS growth quarters	10
EPS growth years	2
Net income growth quarters	8
Net income growth years	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-172,000
Depreciation and amortization	$495,000
EBIT	$-82.8M
EBITDA	$-82.3M
EPS	$-0.93
FCF per share	$-0.51
Financing cash flow	$140.3M
Free cash flow	$-71M
Free cash flow minus SBC	$-81.4M
Investing cash flow	$-65.9M
Net borrowing	$6M
Net cash flow	$3.6M
Net income	$-80.9M
Operating cash flow minus SBC	$-81.2M
Operating income	$-82.8M
Stock-based compensation	$10.4M

Metric

Value

Capital expenditures

$-172,000

Depreciation and amortization

$495,000

EBIT

$-82.8M

EBITDA

$-82.3M

EPS

$-0.93

FCF per share

$-0.51

Financing cash flow

$140.3M

Free cash flow

$-71M

Free cash flow minus SBC

$-81.4M

Investing cash flow

$-65.9M

Net borrowing

$6M

Net cash flow

$3.6M

Net income

$-80.9M

Operating cash flow minus SBC

$-81.2M

Operating income

$-82.8M

Stock-based compensation

$10.4M

Metric	Value
Book value per share	$0.99
Debt / equity	0.08
Interest coverage	-58.84
Long-term assets	$17.4M
Long-term liabilities	$9.9M
Net cash (debt)	$127.2M
Net cash / market cap	78.96%
Net cash growth	101.47%
Net debt / equity	-0.93
Piotroski F-Score	2
Property, plant and equipment	$1.4M
Shareholders' equity	$136.2M
Tangible book value	$136.2M
Tangible book value per share	$0.99
Total assets	$160.8M
Total cash	$138.2M
Total debt	$11M
Total liabilities	$24.6M
WACC	7.07%

Metric

Value

Book value per share

$0.99

Debt / equity

0.08

Interest coverage

-58.84

Long-term assets

$17.4M

Long-term liabilities

$9.9M

Net cash (debt)

$127.2M

Net cash / market cap

78.96%

Net cash growth

101.47%

Net debt / equity

-0.93

Piotroski F-Score

Property, plant and equipment

$1.4M

Shareholders' equity

$136.2M

Tangible book value

$136.2M

Tangible book value per share

$0.99

Total assets

$160.8M

Total cash

$138.2M

Total debt

$11M

Total liabilities

$24.6M

WACC

7.07%

Metric	Value
Current assets	$143.5M
Current liabilities	$14.8M
Current ratio	9.71
Net working capital	$-8.3M
Quick ratio	9.43
Working capital	$128.7M

Metric

Value

Current assets

$143.5M

Current liabilities

$14.8M

Current ratio

9.71

Net working capital

$-8.3M

Quick ratio

9.43

Working capital

$128.7M

Metric	Value
Buyback yield / dilution	-61.42%
Dividend yield	0%
Shareholder yield	-61.42%

Metric

Value

Buyback yield / dilution

-61.42%

Dividend yield

Shareholder yield

-61.42%

Metric	Value
150-day SMA	$1.77
1D price change	6.36%
1M price change	-11.45%
1M total return	-11.45%
1W price change	-6.45%
1W total return	-6.45%
1Y price change	-31.76%
1Y return CAGR	-31.78%
1Y total return	-31.76%
20-day SMA	$1.14
200-day SMA	$1.83
3M price change	-42.57%
3M total return	-42.57%
3Y price change	-82.65%
3Y return CAGR	-44.22%
3Y total return	-82.65%
50-day SMA	$1.55
50-day SMA vs 200-day SMA	50under200
52-week high	$2.66
52-week high date	2026-02-19
52-week low	$0.86
52-week low date	2026-10-15
5Y price change	-97.9%
5Y return CAGR	-53.83%
5Y total return	-97.9%
6M price change	-27.04%
6M total return	-27.04%
All-time high	$117.45
All-time high date	2020-12-10
All-time low	$0.40
All-time low date	2025-06-27
Average true range (ATR)	$0.13
Average volume	1.6M
Beta (1Y)	0.15
Beta (2Y)	0.93
Beta (5Y)	0.48
Change from 52-week high	-56.02%
Change from 52-week low	35.78%
Change from all-time high	-99.01%
Change from all-time low	187.13%
Change from open	8.33%
Day's gap	-1.82%
Dollar volume	$3.3M
High price	$1.19
Low price	$1.04
Monthly RSI	40.24
Open price	$1.08
Position in 52-week range	87.1%
Premarket change	-2.73%
Premarket close	$1.10
Premarket price	$1.07
Previous close	$1.10
Price vs 150-day SMA	-34.43%
Price vs 20-day SMA	1.4%
Price vs 200-day SMA	-36.44%
Price vs 50-day SMA	-24.92%
Relative volume	1.78
Return from IPO open	-96.81%
Return from IPO price	-93.87%
RSI	43.8
Sharpe ratio	-0.01
Sharpe ratio (3Y)	-0.08
Sharpe ratio (5Y)	-0.31
Sortino ratio	0.05
Sortino ratio (3Y)	-0.06
Sortino ratio (5Y)	-0.41
Volume	2.8M
Weekly RSI	36.12
YTD price change	2.66%
YTD total return	2.66%

Metric

Value

150-day SMA

$1.77

1D price change

6.36%

1M price change

-11.45%

1M total return

-11.45%

1W price change

-6.45%

1W total return

-6.45%

1Y price change

-31.76%

1Y return CAGR

-31.78%

1Y total return

-31.76%

20-day SMA

$1.14

200-day SMA

$1.83

3M price change

-42.57%

3M total return

-42.57%

3Y price change

-82.65%

3Y return CAGR

-44.22%

3Y total return

-82.65%

50-day SMA

$1.55

50-day SMA vs 200-day SMA

50under200

52-week high

$2.66

52-week high date

2026-02-19

52-week low

$0.86

52-week low date

2026-10-15

5Y price change

-97.9%

5Y return CAGR

-53.83%

5Y total return

-97.9%

6M price change

-27.04%

6M total return

-27.04%

All-time high

$117.45

All-time high date

2020-12-10

All-time low

$0.40

All-time low date

2025-06-27

Average true range (ATR)

$0.13

Average volume

1.6M

Beta (1Y)

0.15

Beta (2Y)

0.93

Beta (5Y)

0.48

Change from 52-week high

-56.02%

Change from 52-week low

35.78%

Change from all-time high

-99.01%

Change from all-time low

187.13%

Change from open

8.33%

Day's gap

-1.82%

Dollar volume

$3.3M

High price

$1.19

Low price

$1.04

Monthly RSI

40.24

Open price

$1.08

Position in 52-week range

87.1%

Premarket change

-2.73%

Premarket close

$1.10

Premarket price

$1.07

Previous close

$1.10

Price vs 150-day SMA

-34.43%

Price vs 20-day SMA

1.4%

Price vs 200-day SMA

-36.44%

Price vs 50-day SMA

-24.92%

Relative volume

1.78

Return from IPO open

-96.81%

Return from IPO price

-93.87%

RSI

43.8

Sharpe ratio

-0.01

Sharpe ratio (3Y)

-0.08

Sharpe ratio (5Y)

-0.31

Sortino ratio

0.05

Sortino ratio (3Y)

-0.06

Sortino ratio (5Y)

-0.41

Volume

2.8M

Weekly RSI

36.12

YTD price change

2.66%

YTD total return

2.66%

Metric	Value
Float	95M
Float percentage	68.68%
Shares change (QoQ)	29.71%
Shares change (YoY)	61.42%
Shares held by insiders	1.22%
Shares held by institutions	58.5%
Shares outstanding	138.3M
Short % of float	6.29%
Short % of shares	4.32%
Short ratio	5 days

Metric

Value

Float

95M

Float percentage

68.68%

Shares change (QoQ)

29.71%

Shares change (YoY)

61.42%

Shares held by insiders

1.22%

Shares held by institutions

58.5%

Shares outstanding

138.3M

Short % of float

6.29%

Short % of shares

4.32%

Short ratio

5 days

ALX Oncology Holdings Inc. (ALXO)

Price

Financial snapshot

Fair-value bridge

Latest news · ALXO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALXO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ALXO

Frequently asked questions